Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
This agent is not commercially available in the United States and is included for historic purposes only. | This agent is not commercially available in the United States and is included for historic purposes only. | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
| − | *[[Colon cancer]] | + | *[[Colon cancer - historical|Colon cancer]] |
| − | *[[Rectal cancer]] | + | *[[Rectal cancer - historical|Breast cancer]] |
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
*6/18/1990: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. | *6/18/1990: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. | ||
| Line 10: | Line 10: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| + | |||
| + | [[Category:Breast cancer medications (historic)]] | ||
| + | [[Category:Colon cancer medications (historic)]] | ||
[[Category:FDA approved in 1990]] | [[Category:FDA approved in 1990]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Revision as of 02:13, 28 April 2022
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.
Also known as
- Brand name: Ergamisol